Feb 02, 2017 12:01 pm UTC| Business
WYOMISSING, Pa., Feb. 02, 2017 -- Customers Bancorp, Inc. announced that the Board of Directors has declared a quarterly cash dividend on its Fixed-to-Floating Rate Non-Cumulative Perpetual Preferred Stock, Series C...
Feb 02, 2017 12:01 pm UTC| Business
WYOMISSING, Pa., Feb. 02, 2017 -- Customers Bancorp, Inc. announced that the Board of Directors has declared a quarterly cash dividend on its Fixed-to-Floating Rate Non-Cumulative Perpetual Preferred Stock, Series C...
Feb 02, 2017 12:00 pm UTC| Business
VIENNA, Austria, and KING OF PRUSSIA, Pa., Feb. 02, 2017 -- Nabriva Therapeutics AG (NASDAQ:NBRV), a clinical stage biopharmaceutical company engaged in the research and development of novel anti-infective agents to...
Gaming and Leisure Properties, Inc. Announces Fourth Quarter and Full Year 2016 Results
Feb 02, 2017 12:00 pm UTC| Business
- Establishes 2017 First Quarter and Full Year Guidance -- Declares 2017 First Quarter Dividend of $0.62 per Common Share - WYOMISSING, Pa., Feb. 02, 2017 -- Gaming and Leisure Properties,Inc. (NASDAQ:GLPI) (the...
REGENXBIO to Participate in the SunTrust Robinson Humphrey 2017 Orphan Drug Day
Feb 02, 2017 12:00 pm UTC| Business
ROCKVILLE, Md., Feb. 02, 2017 -- REGENXBIO Inc. (Nasdaq:RGNX), a leading biotechnology company focused on the development, commercialization and licensing of recombinant adeno-associated virus (AAV) gene therapy based...
MKS Instruments Reports Fourth Quarter and Full Year 2016 Financial Results
Feb 02, 2017 12:00 pm UTC| Business
Achieved record fourth quarter and full year semi revenueIncreased expected synergies from Newport Corporation acquisition from $35 million to $40 million Successful re-pricing of term loan in Q4 expected to save...
Aptose Biosciences to Present at Canaccord Genuity Rare Disease Biopharma 1x1 Day
Feb 02, 2017 12:00 pm UTC| Business
SAN DIEGO and TORONTO, Feb. 02, 2017 -- Aptose Biosciences Inc. (NASDAQ:APTO) (TSX:APS), a clinical-stage company developing new therapeutics and molecular diagnostics that target the underlying mechanisms of cancer,...